← Leaderboards
Kermit L Carraway
Beth Israel Deaconess Medical Center
$11,333,366
Attributed
$11,333,366
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $906.6K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$11,333,366 · 7
By mechanism
R01$10,970,950 · 6
R21$362,416 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Timothy Vartanian$10,867,825
Others in their field
Top investigators on “Mammary Neoplasms”
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$31,248,413
- Kornelia Polyak · Dana-Farber Cancer Inst$24,040,619
- Lewis A Chodosh · University Of Pennsylvania$21,878,716
- Jeffrey Rosen · Baylor College Of Medicine$18,456,982
- Lawrence H Kushi · Kaiser Foundation Research Institute$17,220,250
- John S Condeelis · Yeshiva University$16,417,177
Research focus
Mammary NeoplasmsMolecularNeoplastic CellSignal TransductionCellsTissuesOverexpressionTumorEventPathway InteractionsMediatingBiochemicalProteinsPropertyPlayTumor ProgressionReceptorReportingResponseErbb2 GeneMalignant NeoplasmsMouse ModelRegulationSolid Neoplasm
Grant awards (54)
Lysosomal-mitochondrial signaling in non-apoptotic cancer cell death$341,181
R01 · FY2024 · CA · contact PI
Lysosomal-mitochondrial signaling in non-apoptotic cancer cell death$79,134
R01 · FY2024 · CA · contact PI
Lysosomal-mitochondrial signaling in non-apoptotic cancer cell death$76,156
R01 · FY2024 · CA · contact PI
Planar cell polarity pathway contribution to breast cancer metastasis$351,955
R01 · FY2023 · CA · contact PI
Lysosomal-mitochondrial signaling in non-apoptotic cancer cell death$351,955
R01 · FY2023 · CA · contact PI
Lysosomal-mitochondrial signaling in non-apoptotic cancer cell death$79,134
R01 · FY2023 · CA · contact PI
Lysosomal-mitochondrial signaling in non-apoptotic cancer cell death$78,168
R01 · FY2023 · CA · contact PI
Lysosomal-mitochondrial signaling in non-apoptotic cancer cell death$45,419
R01 · FY2023 · CA · contact PI
Lysosomal-mitochondrial signaling in non-apoptotic cancer cell death$351,955
R01 · FY2022 · CA · contact PI
Planar cell polarity pathway contribution to breast cancer metastasis$351,955
R01 · FY2022 · CA · contact PI
Lysosomal-mitochondrial signaling in non-apoptotic cancer cell death$79,563
R01 · FY2022 · CA · contact PI
Planar cell polarity pathway contribution to breast cancer metastasis$75,829
R01 · FY2022 · CA · contact PI
Planar cell polarity pathway contribution to breast cancer metastasis$436,515
R01 · FY2021 · CA · contact PI
Lysosomal-mitochondrial signaling in non-apoptotic cancer cell death$359,138
R01 · FY2021 · CA · contact PI
Planar cell polarity pathway contribution to breast cancer metastasis$359,138
R01 · FY2020 · CA · contact PI
Lysosomal-mitochondrial signaling in non-apoptotic cancer cell death$359,138
R01 · FY2020 · CA · contact PI
Planar cell polarity pathway contribution to breast cancer metastasis$47,254
R01 · FY2020 · CA · contact PI
Planar cell polarity pathway contribution to breast cancer metastasis$359,138
R01 · FY2019 · CA · contact PI
Muc4 Involvement in Mammary Tumor Progression$277,200
R01 · FY2017 · CA · contact PI
Muc4 Involvement in Mammary Tumor Progression$71,009
R01 · FY2017 · CA · contact PI
Muc4 Involvement in Mammary Tumor Progression$277,200
R01 · FY2016 · CA · contact PI
NRDP1 PROTEIN DEGRADATION PATHWAY IN MAMMARY TUMOR PROGRESSION$238,880
R01 · FY2016 · CA · contact PI
Muc4 Involvement in Mammary Tumor Progression$64,505
R01 · FY2016 · CA · contact PI
Muc4 Involvement in Mammary Tumor Progression$277,200
R01 · FY2015 · CA · contact PI
NRDP1 PROTEIN DEGRADATION PATHWAY IN MAMMARY TUMOR PROGRESSION$238,880
R01 · FY2015 · CA · contact PI
NRDP1 PROTEIN DEGRADATION PATHWAY IN MAMMARY TUMOR PROGRESSION$17,793
R01 · FY2015 · CA · contact PI
Muc4 Involvement in Mammary Tumor Progression$268,884
R01 · FY2014 · CA · contact PI
NRDP1 PROTEIN DEGRADATION PATHWAY IN MAMMARY TUMOR PROGRESSION$231,713
R01 · FY2014 · CA · contact PI
Novel method of identifying circulating mammary tumor cells$194,941
R21 · FY2014 · CA · contact PI
NRDP1 PROTEIN DEGRADATION PATHWAY IN MAMMARY TUMOR PROGRESSION$57,925
R01 · FY2014 · CA · contact PI
Muc4 Involvement in Mammary Tumor Progression$277,200
R01 · FY2013 · CA · contact PI
NRDP1 PROTEIN DEGRADATION PATHWAY IN MAMMARY TUMOR PROGRESSION$224,547
R01 · FY2013 · CA · contact PI
Novel method of identifying circulating mammary tumor cells$167,475
R21 · FY2013 · CA · contact PI
NRDP1 PROTEIN DEGRADATION PATHWAY IN MAMMARY TUMOR PROGRESSION$230,387
R01 · FY2012 · CA · contact PI
Modulation of ErbB Receptor Tyrosine Kinase Signaling$57,169
R01 · FY2011 · GM · contact PI
Nrdp1 Protein Degradation Pathway in Mammary Tumor Progression$27,170
R01 · FY2011 · CA · contact PI
Modulation of ErbB Receptor Tyrosine Kinase Signaling$271,533
R01 · FY2010 · GM · contact PI
Nrdp1 Protein Degradation Pathway in Mammary Tumor Progression$235,778
R01 · FY2010 · CA · contact PI
Modulation of ErbB Receptor Tyrosine Kinase Signaling$283,914
R01 · FY2009 · GM · contact PI
Nrdp1 Protein Degradation Pathway in Mammary Tumor Progression$235,778
R01 · FY2009 · CA · contact PI
Modulation of ErbB Receptor Tyrosine Kinase Signaling$61,763
R01 · FY2009 · GM · contact PI
Modulation of ErbB Receptor Tyrosine Kinase Signaling$48,023
R01 · FY2009 · GM · contact PI
Modulation of ErbB Receptor Tyrosine Kinase Signaling$274,275
R01 · FY2008 · GM · contact PI
Nrdp1 Protein Degradation Pathway in Mammary Tumor Progression$235,778
R01 · FY2008 · CA · contact PI
Modulation of ErbB Receptor Tyrosine Kinase Signaling$296,831
R01 · FY2007 · GM · contact PI
Nrdp1 Protein Degradation Pathway in Mammary Tumor Progression$235,520
R01 · FY2007 · CA · contact PI
Nrdp1 Protein Degradation Pathway in Mammary Tumor Progression$259,771
R01 · FY2006 · CA · contact PI
Modulation of ErbB Receptor Tryosine Kinase Signaling$244,536
R01 · FY2006 · GM · contact PI
Modulation of ErbB Receptor Tryosine Kinase Signaling$287,948
R01 · FY2005 · GM
Modulation of ErbB Receptor Tryosine Kinase Signaling$287,948
R01 · FY2004 · GM
Modulation of ErbB Receptor Tryosine Kinase Signaling$242,682
R01 · FY2003 · GM
Modulation of ErbB Receptor Tryosine Kinase Signaling$37,611
R01 · FY2003 · GM
HETERODIMERIZATION AND ERBB RECEPTOR SIGNALING$195,464
R01 · FY2001 · CA
HETERODIMERIZATION AND ERBB RECEPTOR SIGNALING$215,410
R01 · FY2000 · CA